¼¼°èÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Eye Care Supplement Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â ¼¼°èÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼´Â µ¿ÀÎ, Ãß¼¼, ±âȸ ¹× °úÁ¦¿Í °°Àº Áß¿äÇÑ ½ÃÀå ¿ªÇп¡ ´ëÇÑ Ã¶ÀúÇÑ Æò°¡¸¦ Á¦°øÇÏ¿© ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ¿¬±¸ °£Ç๰Àº 2025³âºÎÅÍ 2032³â±îÁö ±Û·Î¹ú ¾È°ú º¸Á¶Á¦ ½ÃÀåÀÇ ¿¹»ó ¼ºÀå ±ËÀûÀ» ¼³¸íÇÏ´Â µ¶Á¡ µ¥ÀÌÅÍ¿Í Åë°è¸¦ Á¦°øÇÕ´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
´« °ü¸® º¸Á¶Á¦ ½ÃÀå ±Ô¸ð(2025³â) : 183¾ï ´Þ·¯
¿¹Ãø ½ÃÀå °¡Ä¡(2032³â) : 251¾ï ´Þ·¯
CAGR(2025-2032³â) : 4.6%
´« °ü¸® º¸Á¶Á¦ ½ÃÀå : º¸°í ¹üÀ§
´« °ü¸® º¸Á¶Á¦´Â ´« °Ç°À» °³¼±ÇÏ°í ½Ã·Â °ü·Ã ÁúȯÀÇ À§ÇèÀ» ÁÙÀ̸ç Àü¹ÝÀûÀÎ ´« ±â´ÉÀ» Áö¿øÇϵµ·Ï ¼³°èµÈ ½ÄÀÌ º¸Á¶Á¦ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ º¸ÃæÁ¦¿¡´Â ÀϹÝÀûÀ¸·Î ºñŸ¹Î(ºñŸ¹Î A, C, E µî), ¹Ì³×¶ö(¾Æ¿¬, ¼¿·¹´½ µî), Ç×»êÈÁ¦, ·çÅ×ÀÎ ¹× Á¦¾ÆÀÜÆ¾°ú °°Àº ±âŸ ¿µ¾ç¼Ò µîÀÇ ¼ººÐÀÌ ÇÔÀ¯µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº Ȳ¹Ýº¯¼º, ¹é³»Àå, ¾È±¸°ÇÁ¶Áõ°ú °°Àº ³ëÈ¿Í °ü·ÃµÈ ´« ¹®Á¦¸¦ ¿¹¹æÇϰíÀÚ ÇÏ´Â °³Àΰú ÀϹÝÀûÀÎ ´« °Ç° À¯Áö¸¦ ¿øÇÏ´Â »ç¶÷µéÀ» ´ë»óÀ¸·Î ÇÕ´Ï´Ù. ´« °Ç°ÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ¼ÒºñÀÚ ÀÎ½Ä Áõ°¡, ´« °ü·Ã ÁúȯÀÇ Áõ°¡, ´« °Ç° ÁõÁøÀ» À§ÇÑ º¸ÃæÁ¦ Á¦ÇüÀÇ ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
¼¼°èÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀåÀº Ȳ¹Ýº¯¼º, ¹é³»Àå, ³ì³»Àå°ú °°Àº ´« °Ç° ¹®Á¦°¡ ¹ß»ýÇϱ⠽¬¿î Àα¸ °í·Éȸ¦ ºñ·ÔÇÑ ¸î °¡Áö ÁÖ¿ä ¿äÀο¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àå½Ã°£ ½ºÅ©¸° »ç¿ëÀ¸·Î ÀÎÇÑ µðÁöÅÐ ´«ÀÇ ÇǷΰ¡ Áõ°¡ÇÔ¿¡ µû¶ó ´«À» º¸È£ÇÏ°í ¿µ¾çÀ» °ø±ÞÇÏ´Â º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼ÒºñÀÚµéÀÇ °Ç°¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ½Ã·Â ¼Õ»óÀ» ¹æÁöÇϱâ À§ÇÑ ¿¹¹æÃ¥À» Àû±ØÀûÀ¸·Î ¸ð»öÇÏ¸é¼ ´« °Ç° º¸Á¶Á¦¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁ³½À´Ï´Ù. »ýü ÀÌ¿ë·üÀÌ ³ô°í È¿°úÀûÀÎ Á¦ÇüÀÇ °³¹ß°ú °°Àº º¸ÃæÁ¦ »ý»êÀÇ ±â¼ú ¹ßÀüµµ ½ÃÀå È®´ë¸¦ À̲ø°í ÀÖ½À´Ï´Ù. ¿ÀÇÁ¶óÀÎ ¸ÅÀå°ú ¿Â¶óÀÎ Ç÷§Æû ¸ðµÎ¿¡¼ ´« °Ç° º¸Á¶Á¦ÀÇ °¡¿ë¼ºÀÌ Áõ°¡ÇÏ¸é¼ ½ÃÀå ¼ºÀå¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸ÇÏ°í ´« °ü¸® º¸Á¶Á¦ ½ÃÀåÀº º¸Á¶Á¦ÀÇ È¿´É°ú ¾ÈÀü¼º¿¡ °üÇÑ Áö¿ª¸¶´Ù ´Ù¾çÇÑ ±âÁØÀÌ Àû¿ëµÇ´Â ±ÔÁ¦ Á¶»ç¿Í °ü·ÃµÈ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀϺΠƯ¼ö º¸ÃæÁ¦ÀÇ ³ôÀº °¡°ÝÀ¸·Î ÀÎÇØ ƯÈ÷ °¡Ã³ºÐ ¼ÒµæÀÌ ³·Àº °³¹ßµµ»ó±¹¿¡¼´Â Á¢±Ù¼ºÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Á¦¾à ¿äÀÎÀ¸·Î´Â ƯÁ¤ ´« °ü¸® º¸Á¶Á¦ÀÇ È¿°ú¿¡ ´ëÇÑ Á¦Á¶¾÷üÀÇ ÁÖÀåÀ» µÞ¹ÞħÇÏ´Â Á¾ÇÕÀûÀÎ °úÇÐÀû Áõ°Å°¡ ºÎÁ·ÇÏ¿© ¼ÒºñÀÚ ½Å·Ú¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ´Ù´Â Á¡ÀÌ ÀÖ½À´Ï´Ù.
½ÃÀå ±âȸ
´« °Ç° º¸Á¶Á¦ ½ÃÀåÀº ±â¼ú Çõ½Å, Àα¸ Åë°èÇÐÀû º¯È, ¼ÒºñÀÚ ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È·Î ÀÎÇØ »ó´çÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ´« °Ç°À» ¸ð´ÏÅ͸µÇÏ°í º¸ÃæÁ¦¸¦ ¼·ÃëÇÏ´Â ½º¸¶Æ®Æù ¾Û°ú °°Àº µðÁöÅÐ °Ç° ±â¼úÀÇ ÅëÇÕÀº ¼ÒºñÀÚ Âü¿©¸¦ ³ôÀÌ°í ½ÃÀå Âü¿©ÀÚ¿¡°Ô »õ·Î¿î ±æÀ» ¿¾îÁÝ´Ï´Ù. ¶ÇÇÑ Ãµ¿¬ ¹× À¯±â³ó º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½ÉÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¦Á¶¾÷ü´Â ´« °Ç°À» Áö¿øÇÏ´Â ½Ä¹°¼º ¿ø·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ È®´ëÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇϱâ À§Çؼ´Â Àü·«Àû ÆÄÆ®³Ê½Ê, ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ, ÀÓ»óÀûÀ¸·Î ÀÔÁõµÈ »õ·Î¿î ´« °Ç° º¸Á¶Á¦ÀÇ µµÀÔÀÌ ÇʼöÀûÀÔ´Ï´Ù. Áß»êÃþ Àα¸°¡ Áõ°¡ÇÏ´Â ½ÅÈï ½ÃÀåÀ¸·Î ÁøÃâÇÏ´Â °Íµµ ´« °Ç° º¸Á¶Á¦ ¾÷°è¿¡ Áß¿äÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·ç´Â ÁÖ¿ä Áú¹®
¼¼°èÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
´« °Ç° ÃËÁø¿¡ °¡Àå ÀαâÀÖ´Â ¼ººÐ°ú º¸Á¶Á¦ÀÇ À¯ÇüÀº ¹«¾ùÀΰ¡?
±â¼úÀÇ Áøº¸´Â ´« °ü¸® º¸Á¶Á¦ ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô ¹Ù²Ù°í Àִ°¡?
´« °ü¸® º¸Á¶Á¦ ½ÃÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ±â¾÷°ú ½ÃÀå °ü·Ã¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
¼¼°èÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ°ú Àå·¡¼ºÀº?
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¾ïÁ¦¿äÀÎ
±âȸ
°úÁ¦
ÁÖ¿ä µ¿Çâ
¹æ¹ý : ¼ö¸íÁֱ⠺м®
´« °ü¸® º¸Á¶Á¦ ½ÃÀå : ¹ë·ùüÀÎ
¿øÀç·á °ø±Þ¾÷ü ¸ñ·Ï
Á¦Á¶¾÷ü ¸ñ·Ï
¸®¼¿·¯ ¸ñ·Ï
ó¹æ ¸ñ·Ï
¼öÀͼº ºÐ¼®
Æ÷ÅÍ Five Forces ºÐ¼®
ÁöÁ¤ÇÐÀû ±äÀå : ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
°Å½Ã°æÁ¦ ¿äÀÎ
¼¼°èÀÇ ºÎ¹®º° Àü¸Á
¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
¼¼°èÀÇ »óÀ§ ½ÃÀå °³¿ä
¿¹Ãø ¿äÀÎ : °ü·Ã¼º°ú ¿µÇâ
±ÔÁ¦¿Í ±â¼úÀÇ »óȲ
Á¦3Àå ¼¼°èÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2025-2032³â)
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ±Ô¸ð(´ÜÀ§) ¿¹Ãø
½ÃÀå ±Ô¸ð¿Í Àü³â´ëºñ ¼ºÀå·ü
Àý´ë ¼öÀÍ ±âȸ
½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø
°ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®(2019-2023³â)
ÇöÀç ½ÃÀå ±Ô¸ð ¿¹Ãø(2025-2032³â)
¼¼°èÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå Àü¸Á : ¼ººÐ
¼Ò°³ ¹× ÁÖ¿ä Á¶»ç °á°ú
¼ººÐº° °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ºÐ¼®(2019-2023³â)
¼ººÐº° ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ¿¹Ãø(2025-2032³â)
·çÅ×Àΰú Á¦¾ÆÀÜÆ¾
¿À¸Þ°¡3 Áö¹æ»ê
Ç×»êÈÁ¦
ÄÚ¿£ÀÚÀÓ Q10
Çö󺸳ëÀ̵å
¾ËÆÄ¸®Æ÷»ê
¾Æ½ºÅ¸ÀÜÆ¾
±âŸ
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ¼ººÐ
¼¼°èÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå Àü¸Á : ÀûÀÀÁõ
¼Ò°³ ¹× ÁÖ¿ä Á¶»ç °á°ú
ÀûÀÀÁõº° °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ºÐ¼®(2019-2023³â)
ÀûÀÀÁõº° ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ¿¹Ãø(2025-2032³â)
³ëÈȲ¹Ýº¯¼º(AMD)
¹é³»Àå
¾È±¸°ÇÁ¶Áõ
¿°Áõ
±âŸ
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÁöÇ¥
¼¼°èÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå Àü¸Á : Á¦Á¦
¼Ò°³ ¹× ÁÖ¿ä Á¶»ç °á°ú
Á¦Á¦º° °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ºÐ¼®(2019-2023³â)
Á¦Á¦º° ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ¿¹Ãø(2025-2032³â)
ÅÂºí¸´
ĸ½¶
ºÐ¸»
¼ÒÇÁÆ®Á©
¾×ü
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Çü
¼¼°èÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå Àü¸Á : À¯Åë ä³Î
¼Ò°³ ¹× ÁÖ¿ä Á¶»ç °á°ú
À¯Åëä³Îº° °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ºÐ¼®(2019-2023³â)
À¯Åëä³Îº° ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ¿¹Ãø(2025-2032³â)
¼Ò¸Å ¾à±¹
º´¿ø ¾à±¹
¿Â¶óÀÎ ¾à±¹
¾È°ú ¿ëǰÁ¡
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : À¯Åë ä³Î
Á¦4Àå ¼¼°èÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå Àü¸Á : Áö¿ª
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
2019-2023³â±îÁöÀÇ Áö¿ªº° ½ÃÀå ±Ô¸ð¿Í ¼ö·®(´ÜÀ§)ÀÇ °ú°Å ºÐ¼®
ÇöÀç ½ÃÀå ±Ô¸ð¿Í ¼ö·®ÀÇ Áö¿ªº° ¿¹Ãø(2025-2032³â)
ºÏ¹Ì
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ ¹× ÅÂÆò¾ç
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
½ÃÀåÀÇ ¸Å·Â ºÐ¼® :Áö¿ª
Á¦5Àå ºÏ¹ÌÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2025-2032³â)
Á¦6Àå À¯·´ÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2025-2032³â)
Á¦7Àå µ¿¾Æ½Ã¾ÆÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2025-2032³â)
Á¦8Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2025-2032³â)
Á¦9Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ´« °ü¸® º¸Á¶Á¦ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2025-2032³â)
Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ´« °ü¸® º¸Á¶Á¦ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2025-2032³â)
Á¦11Àå °æÀï ±¸µµ
½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
½ÃÀå ±¸Á¶
½ÃÀ庰 °æÀï °µµ ¸ÅÇÎ
°æÀï ¿À¸Þ°¡ 3 Áö¹æ»ê
¸í¸ñÀû »ý»ê ´É·Â
±â¾÷ ÇÁ·ÎÆÄÀÏ(»ó¼¼ : °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
The Nature&s Bounty Co.
Pfizer Inc.
Vitabiotics Ltd.
Bausch &Lomb
Kemin Industries, Inc.
Amway International
EyeScience
Wellbeing Nutrition
Nutrivein
ZeaVision LLC
Á¦12Àå ºÎ·Ï
Á¶»ç ¹æ¹ý
Á¶»çÀÇ ÀüÁ¦
µÎÀÚ¾î ¹× ¾à¾î
HBR
Persistence Market Research has recently released a comprehensive report on the global eye care supplement market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global eye care supplement market from 2025 to 2032.
Key Insights:
Eye Care Supplement Market Size (2025E): USD 18.3 Billion
Projected Market Value (2032F): USD 25.1 Billion
Global Market Growth Rate (CAGR 2025 to 2032): 4.6%
Eye Care Supplement Market - Report Scope:
Eye care supplements are dietary supplements designed to improve eye health, reduce the risk of vision-related conditions, and support overall eye function. These supplements typically contain ingredients like vitamins (such as Vitamin A, C, and E), minerals (like zinc and selenium), antioxidants, and other nutrients like lutein and zeaxanthin. The market caters to individuals looking to prevent age-related eye issues such as macular degeneration, cataracts, and dry eye syndrome, as well as to those seeking general eye health maintenance. Market growth is driven by increasing consumer awareness regarding the benefits of eye health, rising cases of eye-related disorders, and advancements in supplement formulations aimed at promoting eye wellness.
Market Growth Drivers:
The global eye care supplement market is propelled by several key factors, including an aging population that is more prone to eye health problems such as macular degeneration, cataracts, and glaucoma. The rising prevalence of digital eye strain due to prolonged use of screens has also led to higher demand for supplements that protect and nourish the eyes. Moreover, consumers are becoming more health-conscious and are actively seeking preventative measures to avoid vision impairment, which has spurred interest in eye health supplements. Technological advancements in supplement production, such as the development of more bioavailable and effective formulations, are also driving market expansion. The increased availability of eye care supplements in both physical stores and online platforms has further contributed to the market's growth.
Market Restraints:
Despite promising growth prospects, the eye care supplement market faces challenges related to regulatory scrutiny, with varying standards across regions concerning the efficacy and safety of supplements. Additionally, the high cost of some specialized supplements may limit their accessibility, especially in developing economies with lower disposable incomes. Another restraint is the lack of comprehensive scientific evidence backing the claims made by manufacturers regarding the effectiveness of certain eye care supplements, which could affect consumer confidence.
Market Opportunities:
The eye care supplement market presents significant opportunities driven by technological innovations, demographic shifts, and changing consumer lifestyles. The integration of digital health technologies, such as smartphone apps that monitor eye health and supplement intake, enhances consumer engagement and opens new avenues for market players. Moreover, growing consumer interest in natural and organic supplements provides an opportunity for manufacturers to tap into the expanding demand for plant-based ingredients that support eye health. Strategic partnerships, investment in research and development, and the introduction of new, clinically proven eye care supplements are essential to capitalize on these emerging opportunities. Expanding into emerging markets with growing middle-class populations also presents a valuable growth opportunity for players in the eye care supplement industry.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the eye care supplement market globally?
Which ingredients and supplement types are most popular in promoting eye health?
How are technological advancements reshaping the competitive landscape of the eye care supplement market?
Who are the key players contributing to the eye care supplement market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global eye care supplement market?
Competitive Intelligence and Business Strategy:
Leading players in the global eye care supplement market, including major companies like Pfizer Inc., Amway Corporation, and Herbalife Nutrition, focus on innovation, product diversification, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop effective eye health formulations, targeting specific conditions like macular degeneration, dry eyes, and overall vision support. Collaborations with healthcare providers, nutritionists, and optometrists help boost the credibility of their products and expand market access. Moreover, increasing emphasis on consumer education and the importance of eye care has enhanced awareness, leading to higher adoption of eye care supplements. Investment in clinical trials to validate product claims and the expansion of online retail platforms are crucial strategies for sustaining market growth and meeting consumer demand.
Key Companies Profiled:
Pfizer Inc.
Amway Corporation
Herbalife Nutrition
Bausch & Lomb Incorporated
Alcon Inc.
NaturaLife Labs
ZeaVision LLC
Nature's Way
Swanson Health Products
Jarrow Formulas, Inc.
Eye Care Supplement Market Research Segmentation
By Ingredient:
Lutein and Zeaxanthin
Omega-3 Fatty Acids
Antioxidants
Coenzyme Q10
Flavonoids
Alpha-lipoic Acid
Astaxanthin
By Indication:
Age-related Macular Degeneration (AMD)
Cataract
Dry Eye syndrome
Inflammation
By Formulation:
Tablets
Capsules
Powder
Softgels
Liquid
By Distribution Channel:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Ophthalmic Stores
By Region:
North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa
Table of Contents
1. Executive Summary
1.1. Global Eye Care Supplement Market Snapshot, 2025 - 2032
1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Ingredient Lifecycle Analysis
2.4. Eye Care Supplement Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Formulations
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2019 - 2023
3.2.2. Current Market Size Forecast, 2025 - 2032
3.3. Global Eye Care Supplement Market Outlook: Ingredient
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Ingredient, 2019 - 2023
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
3.3.3.1. Lutein and Zeaxanthin
3.3.3.2. Omega-3 Fatty Acids
3.3.3.3. Antioxidants
3.3.3.4. Coenzyme Q10
3.3.3.5. Flavonoids
3.3.3.6. Alpha-lipoic Acid
3.3.3.7. Astaxanthin
3.3.3.8. Others
3.4. Market Attractiveness Analysis: Ingredient
3.5. Global Eye Care Supplement Market Outlook: Indication
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Indication, 2019 - 2023
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
3.5.3.1. Age-related Macular Degeneration (AMD)
3.5.3.2. Cataract
3.5.3.3. Dry Eye syndrome
3.5.3.4. Inflammation
3.5.3.5. Others
3.6. Market Attractiveness Analysis: Indication
3.7. Global Eye Care Supplement Market Outlook: Formulation
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Formulation, 2019 - 2023
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
3.7.3.1. Tablets
3.7.3.2. Capsules
3.7.3.3. Powder
3.7.3.4. Softgels
3.7.3.5. Liquid
3.8. Market Attractiveness Analysis: Formulation
3.9. Global Eye Care Supplement Market Outlook: Distribution Channel
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2019 - 2023
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
3.9.3.1. Retail Pharmacies
3.9.3.2. Hospital pharmacies
3.9.3.3. Online pharmacies
3.9.3.4. Ophthalmic Stores
3.10. Market Attractiveness Analysis: Distribution Channel
4. Global Eye Care Supplement Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
5.3.1. By Country
5.3.2. By Ingredient
5.3.3. By Indication
5.3.4. By Formulation
5.3.5. By Distribution Channel
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
5.5.1. Lutein and Zeaxanthin
5.5.2. Omega-3 Fatty Acids
5.5.3. Antioxidants
5.5.4. Coenzyme Q10
5.5.5. Flavonoids
5.5.6. Alpha-lipoic Acid
5.5.7. Astaxanthin
5.5.8. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
5.6.1. Age-related Macular Degeneration (AMD)
5.6.2. Cataract
5.6.3. Dry Eye syndrome
5.6.4. Inflammation
5.6.5. Others
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
5.7.1. Tablets
5.7.2. Capsules
5.7.3. Powder
5.7.4. Softgels
5.7.5. Liquid
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
5.8.1. Retail Pharmacies
5.8.2. Hospital pharmacies
5.8.3. Online pharmacies
5.8.4. Ophthalmic Stores
5.9. Market Attractiveness Analysis
6. Europe Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
6.3.1. By Country
6.3.2. By Ingredient
6.3.3. By Indication
6.3.4. By Formulation
6.3.5. By Distribution Channel
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
6.5.1. Lutein and Zeaxanthin
6.5.2. Omega-3 Fatty Acids
6.5.3. Antioxidants
6.5.4. Coenzyme Q10
6.5.5. Flavonoids
6.5.6. Alpha-lipoic Acid
6.5.7. Astaxanthin
6.5.8. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
6.6.1. Age-related Macular Degeneration (AMD)
6.6.2. Cataract
6.6.3. Dry Eye syndrome
6.6.4. Inflammation
6.6.5. Others
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
6.7.1. Tablets
6.7.2. Capsules
6.7.3. Powder
6.7.4. Softgels
6.7.5. Liquid
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
6.8.1. Retail Pharmacies
6.8.2. Hospital pharmacies
6.8.3. Online pharmacies
6.8.4. Ophthalmic Stores
6.9. Market Attractiveness Analysis
7. East Asia Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
7.3.1. By Country
7.3.2. By Ingredient
7.3.3. By Indication
7.3.4. By Formulation
7.3.5. By Distribution Channel
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
7.5.1. Lutein and Zeaxanthin
7.5.2. Omega-3 Fatty Acids
7.5.3. Antioxidants
7.5.4. Coenzyme Q10
7.5.5. Flavonoids
7.5.6. Alpha-lipoic Acid
7.5.7. Astaxanthin
7.5.8. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
7.6.1. Age-related Macular Degeneration (AMD)
7.6.2. Cataract
7.6.3. Dry Eye syndrome
7.6.4. Inflammation
7.6.5. Others
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
7.7.1. Tablets
7.7.2. Capsules
7.7.3. Powder
7.7.4. Softgels
7.7.5. Liquid
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
7.8.1. Retail Pharmacies
7.8.2. Hospital pharmacies
7.8.3. Online pharmacies
7.8.4. Ophthalmic Stores
7.9. Market Attractiveness Analysis
8. South Asia & Oceania Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
8.3.1. By Country
8.3.2. By Ingredient
8.3.3. By Indication
8.3.4. By Formulation
8.3.5. By Distribution Channel
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
8.5.1. Lutein and Zeaxanthin
8.5.2. Omega-3 Fatty Acids
8.5.3. Antioxidants
8.5.4. Coenzyme Q10
8.5.5. Flavonoids
8.5.6. Alpha-lipoic Acid
8.5.7. Astaxanthin
8.5.8. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
8.6.1. Age-related Macular Degeneration (AMD)
8.6.2. Cataract
8.6.3. Dry Eye syndrome
8.6.4. Inflammation
8.6.5. Others
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
8.7.1. Tablets
8.7.2. Capsules
8.7.3. Powder
8.7.4. Softgels
8.7.5. Liquid
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
8.8.1. Retail Pharmacies
8.8.2. Hospital pharmacies
8.8.3. Online pharmacies
8.8.4. Ophthalmic Stores
8.9. Market Attractiveness Analysis
9. Latin America Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
9.3.1. By Country
9.3.2. By Ingredient
9.3.3. By Indication
9.3.4. By Formulation
9.3.5. By Distribution Channel
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
9.5.1. Lutein and Zeaxanthin
9.5.2. Omega-3 Fatty Acids
9.5.3. Antioxidants
9.5.4. Coenzyme Q10
9.5.5. Flavonoids
9.5.6. Alpha-lipoic Acid
9.5.7. Astaxanthin
9.5.8. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
9.6.1. Age-related Macular Degeneration (AMD)
9.6.2. Cataract
9.6.3. Dry Eye syndrome
9.6.4. Inflammation
9.6.5. Others
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
9.7.1. Tablets
9.7.2. Capsules
9.7.3. Powder
9.7.4. Softgels
9.7.5. Liquid
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
9.8.1. Retail Pharmacies
9.8.2. Hospital pharmacies
9.8.3. Online pharmacies
9.8.4. Ophthalmic Stores
9.9. Market Attractiveness Analysis
10. Middle East & Africa Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
10.3.1. By Country
10.3.2. By Ingredient
10.3.3. By Indication
10.3.4. By Formulation
10.3.5. By Distribution Channel
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
10.5.1. Lutein and Zeaxanthin
10.5.2. Omega-3 Fatty Acids
10.5.3. Antioxidants
10.5.4. Coenzyme Q10
10.5.5. Flavonoids
10.5.6. Alpha-lipoic Acid
10.5.7. Astaxanthin
10.5.8. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
10.6.1. Age-related Macular Degeneration (AMD)
10.6.2. Cataract
10.6.3. Dry Eye syndrome
10.6.4. Inflammation
10.6.5. Others
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
10.7.1. Tablets
10.7.2. Capsules
10.7.3. Powder
10.7.4. Softgels
10.7.5. Liquid
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
10.8.1. Retail Pharmacies
10.8.2. Hospital pharmacies
10.8.3. Online pharmacies
10.8.4. Ophthalmic Stores
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2024
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Omega-3 Fatty Acids
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. The Nature's Bounty Co.
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Pfizer Inc.
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Vitabiotics Ltd.
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Bausch & Lomb
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Kemin Industries, Inc.
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Amway International
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. EyeScience
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Wellbeing Nutrition
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Nutrivein
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. ZeaVision LLC
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations